EMEA-001134-PIP01-11
Submitted by Anonymous (not verified) on 2 June 2026 - 12:54
EMEA-001134-PIP01-11
PSUSA/00001263/202507
Submitted by Anonymous (not verified) on 2 June 2026 - 12:18
PSUSA/00001263/202507
Human medicines European public assessment report (EPAR): Akynzeo, netupitant,palonosetron, Date of authorisation: 27/05/2015, Revision: 22, Status: Authorised
Submitted by Anonymous (not verified) on 2 June 2026 - 11:35
Human medicines European public assessment report (EPAR): Akynzeo, netupitant,palonosetron, Date of authorisation: 27/05/2015, Revision: 22, Status: Authorised
Data protection notice for legal entity and bank account validation regarding payments
Submitted by Anonymous (not verified) on 2 June 2026 - 11:00
Data protection notice for legal entity and bank account validation regarding payments
Meeting summaries of the Immunisation and Vaccine Monitoring Advisory Board (IVMAB)
Submitted by Anonymous (not verified) on 2 June 2026 - 10:46
Meeting summaries of the Immunisation and Vaccine Monitoring Advisory Board (IVMAB)
Herbal medicinal product: Lecithinum ex soya, Glycine max (L.) Merr., P: Draft published
Submitted by Anonymous (not verified) on 1 June 2026 - 16:15
Herbal medicinal product: Lecithinum ex soya, Glycine max (L.) Merr., P: Draft published
Human medicines European public assessment report (EPAR): Emadine, emedastine, Date of authorisation: 27/01/1999, Revision: 29, Status: Authorised
Submitted by Anonymous (not verified) on 1 June 2026 - 16:00
Human medicines European public assessment report (EPAR): Emadine, emedastine, Date of authorisation: 27/01/1999, Revision: 29, Status: Authorised
Human medicines European public assessment report (EPAR): Jinarc, tolvaptan, Date of authorisation: 27/05/2015, Revision: 25, Status: Authorised
Submitted by Anonymous (not verified) on 1 June 2026 - 15:52
Human medicines European public assessment report (EPAR): Jinarc, tolvaptan, Date of authorisation: 27/05/2015, Revision: 25, Status: Authorised
Human medicines European public assessment report (EPAR): Capvaxive, pneumococcal polysaccharide conjugate vaccine (21-valent), Date of authorisation: 24/03/2025, Revision: 4, Status: Authorised
Submitted by Anonymous (not verified) on 1 June 2026 - 15:44
Human medicines European public assessment report (EPAR): Capvaxive, pneumococcal polysaccharide conjugate vaccine (21-valent), Date of authorisation: 24/03/2025, Revision: 4, Status: Authorised
Human medicines European public assessment report (EPAR): Zepzelca, lurbinectedin, Date of authorisation: 29/05/2026, Status: Authorised
Submitted by Anonymous (not verified) on 1 June 2026 - 15:32
Human medicines European public assessment report (EPAR): Zepzelca, lurbinectedin, Date of authorisation: 29/05/2026, Status: Authorised